Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer A Phase 1 and Randomized Phase 2 Trial

Cortes, J; Dieras, V; Lorenzen, S; Montemurro, F; Riera-Knorrenschild, J; Thuss-Patience, P; Allegrini, G; De Laurentiis, M; Lohrisch, C; Oravcova, E; Perez-Garcia, JM; Ricci, F; Sakaeva, D; Serpanchy, R; Sufliarsky, J; Vidal, M; Irahara, N; Wohlfarth, C; Aout, M; Gelmon, K

Gelmon, K (corresponding author), Univ British Columbia, Div Med Oncol, 600 W 10th Ave, Vancouver, BC VSZ 4E6, Canada.

JAMA ONCOLOGY, 2020; 6 (8): 1203

Abstract

Question What is the effect of adding capecitabine to trastuzumab emtansine (T-DM1) treatment in patients with previously treated ERBB2 (HER2)-positiv......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索